Allogeneic hematopoietic cell transplantation outcomes in patients with Richter’s transformation

• Haesook T. Kim,
• Peter O. Baker,
• Erin Parry,
• Matthew Davids,
• Edwin P. Alyea,
• Vincent T. Ho,
• Corey Cutler,
• John Koreth,
• Mahasweta Gooptu,
• Rizwan Romee,
• Sarah Nikiforow,
• Joseph H. Antin,
• Jerome Ritz,
• Robert J. Soiffer,
• Catherine J. Wu,
• Jennifer R. Brown

Affiliations

Haesook T. Kim

Department of Data Science, Dana Farber Cancer Institute, Harvard School of Public Health, Boston

Peter O. Baker

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston

Erin Parry

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston

Matthew Davids

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston

Edwin P. Alyea

Duke Cancer Institute, Duke Medical School, Durham

Vincent T. Ho

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston

Corey Cutler

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston

John Koreth

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston

Mahasweta Gooptu

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston

Rizwan Romee

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston

Sarah Nikiforow

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston

Joseph H. Antin

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston

Jerome Ritz

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston

Robert J. Soiffer

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston

Catherine J. Wu

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston

Jennifer R. Brown

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston